CNS Pharmaceuticals logo
CNS Pharmaceuticals CNSP
$ 0.11 -1.73%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

CNS Pharmaceuticals Financial Statements 2011-2024 | CNSP

Annual Financial Statements CNS Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.32 M 1.54 M 528 K 28.4 M 59.4 M - - - - - - - -

Shares

3.77 M 1.36 M 878 K 16.5 M 13.6 M - - - - - - - -

Historical Prices

0.35 1.13 0.601 1.72 4.31 - - - - - - - -

Net Income

-18.9 M -15.3 M -14.5 M -9.46 M -3.88 M -7.39 M - - - - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-18.9 M -15.3 M -14.5 M -9.45 M -3.83 M -882 K - - - - - - -

Interest Expense

13.8 K 7.03 K 9.28 K 3.26 K 26.2 K 28.6 K - - - - - - -

EBITDA

-18.9 M -15.3 M -14.5 M -9.44 M -3.83 M -7.35 M - - - - - - -

Operating Expenses

18.9 M 15.3 M 14.5 M 9.45 M 3.83 M - - - - - - - -

General and Administrative Expenses

4.77 M 5.97 M 4.68 M 4.39 M 1.98 M 861 K - - - - - - -

All numbers in USD currency

Quarterly Income Statement CNS Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

22.2 M 377 K 8.71 M 124 K 83.5 K 77.5 K 1.91 M 1.62 M 1.33 M 1.33 M 1.29 M 27.9 M 27.4 M 25.4 M 24.7 M 23.9 M 16.5 M 16.5 M 16.5 M 16.5 M 13.6 M 13.2 M 12.7 M 16.5 M 10.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-5.61 M -2.53 M -3.54 M - -4.52 M -4.02 M -4.93 M - -3.42 M -3.57 M -3.15 M - -3.81 M -3.81 M -3.61 M - -2.01 M -2.47 M -1.97 M - -707 K -432 K -212 K - -193 K -257 K -310 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - 76.1 K 65.8 K 48.7 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-5.63 M -2.53 M -3.54 M - -4.53 M -4.03 M -4.93 M - -3.42 M -3.56 M -3.15 M - -3.81 M -3.81 M -3.61 M - -2.01 M -2.47 M -1.97 M - -699 K -415 K -195 K - -170 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - 6.62 K - 1.84 K 3.65 K 5.44 K - 538 1.61 K 2.57 K - 947 2.35 K 3.75 K - - - - - 7.56 K 7.48 K 7.49 K - 10.6 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -3.54 M - - - -4.93 M - -3.41 M -3.56 M -3.15 M - -3.8 M -3.81 M -3.61 M - -2 M -2.47 M -1.97 M - -698 K -415 K -195 K - -170 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

5.63 M 2.53 M 3.54 M - 4.53 M 4.03 M 4.93 M - 3.42 M 3.56 M 3.15 M - 3.81 M 3.81 M 3.61 M - 2.01 M 2.47 M 1.97 M - 699 K 415 K 195 K - 170 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

1.38 M 1.41 M 1.11 M - 1.12 M 1.18 M 1.36 M - 1.21 M 1.34 M 1.26 M - 1.24 M 1.15 M 1.4 M - 969 K 981 K 1.36 M - 373 K 372 K 147 K - 165 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency